SYS-CON MEDIA Authors: David H Deans, RealWire News Distribution, Gilad Parann-Nissany, Kevin Benedict, Unitiv Blog

News Feed Item

FDA Approves New Pulsaderm LED Blue

Launch Adds to Pulsaderm's Growing Line of Affordable Skincare Solutions

LAS VEGAS,NV--(Marketwired - July 14, 2014) - Pulsaderm, the U.S.-based skincare line that offers a family of state-of-the-art skincare devices at affordable prices, is proud to announce the launch of the FDA-Cleared Pulsaderm LED Blue at this year's Cosmoprof North America. The FDA-approved Class II Medical Device is available for $189 and is specially designed with advanced blue light LED technology to deliver a non-invasive and painless treatment for mild to moderate inflammatory acne. With competing FDA-Cleared light therapy devices often selling at well over $500, Pulsaderm is providing a safe, effective and affordable alternative.

"We are ecstatic that Pulsaderm LED Blue has been rigorously tested and approved by the FDA," said Pulsaderm Founder and CEO Yvonne von Berg. "Following the enormous success of the launch of Pulsaderm and Pulsaderm Buddy facial cleansing brushes, adding Pulsaderm LED Blue seems like a natural addition to the brand's growing line of affordable and effective beauty products."

Pulsaderm LED Blue has taken blue light therapy utilized by many dermatologists and developed an over-the-counter version that can be used by both professionals and consumers. The device employs wavelengths of light at a frequency of 415 nanometers (nm), which penetrates into the skin's pores to activate light-sensitive porphyrins, located in the outer cell membranes of acne or acne-causing bacteria. When porphyrins are exposed to certain wavelengths of light, they produce free radicals that kill the acne-causing bacteria without harming healthy skin. Utilizing 97 non-damaging LED lights, the Pulsaderm LED Blue offers nearly four times as much power as most of its competitors, guaranteeing faster results for clearer, blemish-free skin.

"With innovative advancements serving as the backbone of Pulsaderm, it's in the brand's DNA to revolutionize skincare," adds von Berg. "All of the Pulsaderm products were created in an effort to prevent and resolve skincare problems at affordable prices. By incorporating the latest cutting-edge technology in each product throughout the line, Pulsaderm aims to deliver a new sense of clean."

Blue light therapy is 100 percent natural and non-invasive. The acne treatment process is drug-free with no adverse side effects, short or long term, and is safe for daily use by all ages, revealing visible improvements with each use. Pulsaderm LED Blue is a gentle and painless solution to acne that will continue working over time resulting in smoother, more-hydrated and glowing skin.

Pulsaderm LED Blue is available for $189 -- a steal compared to competitors -- and can be found, along with its sister products, Pulsaderm and Pulsaderm Buddy, at www.pulsaderm.com and at select retailers nationwide.

PULSADERM
Pulsaderm is a line of innovative skincare devices that feature advanced proprietary technology to deliver effective results. Their mission is to enhance skin health by offering expertly engineered skincare solutions at an affordable price. Currently, the Pulsaderm line includes the Pulsaderm and Pulsaderm Buddy facial cleansing brushes as well as the FDA-Cleared Class II Pulsaderm LED Blue. Pulsaderm's parent company, NutraLuxe MD, prides itself on developing quality skincare products. NutraLuxe MD was founded in the U.S. in 2004 with a mission to use the latest technological advances to create better skincare solutions for both men and women. NutraLuxe MD is designed and assembled in the U.S. For more information, please visit www.pulsaderm.com.

Image Available: http://www.marketwire.com/library/MwGo/2014/6/30/11G017656/Images/pulsaderm_product_LED_03__79053.1402351852.545.545-297156151551.jpg

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.